Transfusion-transmitted infections

Although the risk of transfusion-transmitted infections today is lower than ever, the supply of safe blood products remains subject to contamination with known and yet to be identified human pathogens. Only continuous improvement and implementation of donor selection, sensitive screening tests and e...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of translational medicine Jg. 5; H. 1; S. 25
Hauptverfasser: Bihl, Florian, Castelli, Damiano, Marincola, Francesco, Dodd, Roger Y, Brander, Christian
Format: Journal Article
Sprache:Englisch
Veröffentlicht: England BioMed Central Ltd 06.06.2007
BioMed Central
BMC
Schlagworte:
Bacterial infections
Bacterial Infections - etiology
Bacterial Infections - prevention & control
Blood transfusion
Complications and side effects
Disease Transmission, Infectious - prevention & control
Evaluation
Humans
Patient outcomes
Prion Diseases - etiology
Prion Diseases - prevention & control
Protozoan Infections - etiology
Protozoan Infections - prevention & control
Review
Risk factors
Transfusion Reaction
TT virus infections
Virus Diseases - etiology
Virus Diseases - prevention & control
United States
Switzerland
ISSN:1479-5876, 1479-5876
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Although the risk of transfusion-transmitted infections today is lower than ever, the supply of safe blood products remains subject to contamination with known and yet to be identified human pathogens. Only continuous improvement and implementation of donor selection, sensitive screening tests and effective inactivation procedures can ensure the elimination, or at least reduction, of the risk of acquiring transfusion transmitted infections. In addition, ongoing education and up-to-date information regarding infectious agents that are potentially transmitted via blood components is necessary to promote the reporting of adverse events, an important component of transfusion transmitted disease surveillance. Thus, the collaboration of all parties involved in transfusion medicine, including national haemovigilance systems, is crucial for protecting a secure blood product supply from known and emerging blood-borne pathogens.
Bibliographie:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
ObjectType-Review-3
content type line 23
ISSN:1479-5876
1479-5876
DOI:10.1186/1479-5876-5-25